Skip to content

Cardiometabolic Disease Risk Factors in Cameroon

Screening for Cardiometabolic Disease Risk Factors: a Community Health Screening Program in Urban Cameroon

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06957548
Acronym
URBACAM-D
Enrollment
200
Registered
2025-05-04
Start date
2025-07-09
Completion date
2027-02-12
Last updated
2025-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Disease, Metabolic Disease

Brief summary

Cardiometabolic diseases (CMDs) are a major public health concern in sub-Saharan Africa, including Cameroon. Studies have shown a significant increase in the prevalence of hypertension, diabetes, and obesity in recent years. However, access to timely diagnosis and treatment remains limited, particularly in rural areas. Community-based screening programs have been shown to be effective in identifying individuals with undiagnosed CMD risk factors and promoting early intervention. By leveraging the strengths of community-based approaches, the URBACAM-D study aims to address the growing burden of CMDs in urban Cameroon.

Interventions

DIAGNOSTIC_TESTCardiometabolic disease

Cardiometabolic disease screening

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Screening is open to any adult over the age of 18 years

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of Cardiometabolic disease risk factors in Urban Cameroon1 yearTo determine the prevalence of undiagnosed and uncontrolled cardiometabolic disease (CMD) risk factors among urban Cameroonians.

Countries

Cameroon

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026